Provided by Tiger Trade Technology Pte. Ltd.

Madrigal Pharmaceuticals

544.41
-1.7800-0.33%
Post-market: 544.860.4500+0.08%17:20 EST
Volume:348.43K
Turnover:189.60M
Market Cap:12.36B
PE:-41.76
High:555.50
Open:546.00
Low:535.33
Close:546.19
52wk High:605.00
52wk Low:265.00
Shares:22.71M
Float Shares:11.00M
Volume Ratio:1.42
T/O Rate:3.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.0355
EPS(LYR):-21.9007
ROE:-41.22%
ROA:-15.78%
PB:19.76
PE(LYR):-24.86

Loading ...

Madrigal Pharmaceuticals to Release Third-Quarter 2025 Financial Results and Host Webcast on November 4, 2025

GlobeNewswire
·
Oct 22

BRIEF-Madrigal Pharmaceuticals Announces Grants Of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Oct 22

How Investors Are Reacting To Madrigal Pharmaceuticals (MDGL) Analyst Upgrades on New MASH Drug Launch

Simply Wall St.
·
Oct 18

Madrigal Pharmaceuticals Initiated at Buy by Truist Securities

Dow Jones
·
Oct 15

U.S. RESEARCH ROUNDUP- BlackRock, EQT, Ovintiv

Reuters
·
Oct 15

Madrigal Pharmaceuticals Inc : Piper Sandler Raises Target Price to $540 From $400

THOMSON REUTERS
·
Oct 15

Madrigal Pharmaceuticals: Strong Growth Potential Driven by Rezdiffra’s Market Leadership and Strategic Opportunities

TIPRANKS
·
Oct 15

Madrigal Pharmaceuticals initiated with a Buy at Truist

TIPRANKS
·
Oct 15

Madrigal Pharmaceuticals price target raised to $590 from $500 at Oppenheimer

TIPRANKS
·
Oct 10

BRIEF-Madrigal Pharmaceuticals Announces Grants Of Inducement Awards

Reuters
·
Oct 08

Madrigal Pharmaceuticals Is Maintained at Buy by B. Riley Securities

Dow Jones
·
Sep 29

B. Riley Raises Price Target on Madrigal Pharmaceuticals to $560 From $460, Keeps Buy Rating

MT Newswires Live
·
Sep 29

Madrigal Pharmaceuticals Inc : B. Riley Raises Target Price to $560 From $460

THOMSON REUTERS
·
Sep 29

Madrigal Pharmaceuticals (MDGL) Gets a Buy from UBS

TIPRANKS
·
Sep 24

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 19

Madrigal Pharmaceuticals management to meet with B. Riley

TIPRANKS
·
Sep 16

Madrigal Pharmaceuticals (MDGL) Receives a Buy from Canaccord Genuity

TIPRANKS
·
Sep 12

Madrigal Pharmaceuticals Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Sep 12

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 05

Madrigal Pharmaceuticals Inc : H.c. Wainwright Assumes Coverage With Buy Rating; Target Price $500

THOMSON REUTERS
·
Sep 04